We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$919M
AUM Growth
+$100M
Cap. Flow
+$8.56M
Cap. Flow %
0.93%
Top 10 Hldgs %
73.95%
Holding
3,000
New
528
Increased
1,514
Reduced
448
Closed
116
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADMA icon
1751
ADMA Biologics
ADMA
$2.02B
$2.13K ﹤0.01%
255
+211
+480% +$1.92K
GOLF icon
1752
Acushnet Holdings
GOLF
$6B
$2.13K ﹤0.01%
18
+8
+80% +$765
INDV icon
1753
Indivior Pharmaceuticals
INDV
$4.74B
$2.13K ﹤0.01%
52
+47
+940% +$1.71K
LEN.B icon
1754
Lennar Class B
LEN.B
$19.9B
$2.13K ﹤0.01%
24
+20
+500% +$1.75K
ZGN icon
1755
Zegna
ZGN
$4.01B
$2.12K ﹤0.01%
+163
New +$2.1K
JEDI
1756
Defiance Drone and Modern Warfare ETF
JEDI
$123M
$2.12K ﹤0.01%
+73
New +$2.25K
BDX icon
1757
Becton Dickinson
BDX
$46.4B
$2.12K ﹤0.01%
14
-3
-18% -$449
NRC icon
1758
NRC Health Common Stock
NRC
$405M
$2.11K ﹤0.01%
+98
New +$1.82K
QGEN icon
1759
Qiagen
QGEN
$8.62B
$2.11K ﹤0.01%
+54
New +$2.01K
MCRI icon
1760
Monarch Casino & Resort
MCRI
$2.2B
$2.11K ﹤0.01%
16
UPWK icon
1761
Upwork
UPWK
$1.18B
$2.09K ﹤0.01%
250
+238
+1,983% +$2.25K
KOS icon
1762
Kosmos Energy
KOS
$1.47B
$2.08K ﹤0.01%
+987
New +$2.75K
DLX icon
1763
Deluxe
DLX
$1.25B
$2.08K ﹤0.01%
+87
New +$2.27K
FLS icon
1764
Flowserve
FLS
$8.94B
$2.08K ﹤0.01%
28
-1
-3% -$76
BY icon
1765
Byline Bancorp
BY
$1.78B
$2.07K ﹤0.01%
55
+37
+206% +$1.24K
ESAB icon
1766
ESAB
ESAB
$5.37B
$2.07K ﹤0.01%
21
+5
+31% +$483
CAR icon
1767
Avis
CAR
$5.47B
$2.07K ﹤0.01%
14
+10
+250% +$2.2K
TENB icon
1768
Tenable Holdings
TENB
$3.47B
$2.07K ﹤0.01%
56
-2
-3% -$47
BLMN icon
1769
Bloomin' Brands
BLMN
$754M
$2.06K ﹤0.01%
225
+80
+55% +$582
LPG icon
1770
Dorian LPG
LPG
$1.96B
$2.05K ﹤0.01%
59
-77
-57% -$3.03K
MGNI icon
1771
Magnite
MGNI
$2.83B
$2.05K ﹤0.01%
108
+25
+30% +$358
WRBY icon
1772
Warby Parker
WRBY
$3.19B
$2.03K ﹤0.01%
67
+47
+235% +$1.16K
VRDN icon
1773
Viridian Therapeutics
VRDN
$2.2B
$2.02K ﹤0.01%
+110
New +$1.77K
HBT icon
1774
HBT Financial
HBT
$1.33B
$2.02K ﹤0.01%
63
+59
+1,475% +$1.7K
ZYME icon
1775
Zymeworks
ZYME
$1.62B
$2.01K ﹤0.01%
+77
New +$1.96K

Similar funds

SJS Investment Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, SJS Investment Consulting held 3,000 positions worth $919M, up 12% from $819M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

SJS Investment Consulting's Q2 2026 filing shows 528 new, 1,514 increased, 448 reduced and 116 closed positions. Its largest new stake was Kestra Medical Technologies: 20,060 shares worth $510K. The largest sale was Dimensional Short-Duration Fixed Income ETF, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5% a quarter earlier, followed by Healthcare and Consumer Staples.

  • SJS Investment Consulting's largest Q2 2026 buy was Kestra Medical Technologies: 20,060 shares worth $510K.
  • SJS Investment Consulting added most to Dimensional US Core Equity 2 ETF in Q2 2026, an estimated $6.25M increase.
  • SJS Investment Consulting's biggest Q2 2026 reduction was Dimensional Short-Duration Fixed Income ETF, cutting an estimated $17.6M.
  • SJS Investment Consulting fully exited Vanguard Short Duration Bond ETF in Q2 2026, selling an estimated $299K.
  • SJS Investment Consulting's ten largest holdings make up 74% of its $919M portfolio in Q2 2026.
  • SJS Investment Consulting opened 528 new positions and closed 116 in Q2 2026.
  • SJS Investment Consulting's portfolio value rose 12% quarter-over-quarter to $919M.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.